少妇激情艳情综合小视频_一区二区三区亚洲69xx_噜噜久久噜噜久久鬼88_激情av福利_久久婷婷色香五月综合激激情,狠狠做五月_欧美日韩一区二区中文字幕_国产精品理论在线观看亚欧美少妇影院_亚洲午夜久久久久亚洲国产精品午夜福利_超碰对碰在线观看_五月天色色婷_黄片动态视频_欧美一区二区三区国产_欧美女同一区二区_国产麻豆一区二区三区视频_天天躁夜夜躁狠狠久久 ,不卡免费高清中文字幕_日韩激情中文字幕一区二区_亚洲av综合网一区二区_国产自拍av一区_亚洲国产日韩精品在线观看_国产在线视频首页_午夜色视频一区二区_超碰日日夜夜亚洲欧美日韩国产色另类_奇米久久996_妓女一级淫荡免费A片Sy_强奷乱码中文字幕在线观看_波多野结衣无码啪啪1000_欧美一区二区久久_黑人大战欲求不满人妻_欧美亚洲中文日韩 ,久久精品人妻少妇aⅴ一区二区_国产一区二区正在播放_三上悠亚在线播放一区二区视频_国产毛片女人精品_日韩国产小视频_15小男生gay自慰脱裤子_亚洲一区二区三区四区免费视频av在线亚洲天堂_国产欧美日韩视频国产综合有码无码中文字幕_在线看无码av_亚洲中文字幕av暧暧_电影网站AV波多香蕉_国产成人精品免费看在线播放_国产太嫩了在线观看_国产一区日韩二区欧美三区

Webinar banner titled "Unlocking Discovery and Enabling Clinical Evaluation: Predicting Human Pharmacokinetics and Dose." Features headshots of Hannah Jones, Vice President of PBPK Consulting Services at Certara UK Limited, and Simon Taylor, Vice President of DMPK at Pharmaron. Includes insights into preclinical ADME studies.

Capabilities

Recorded: February 2022

This webinar will cover strategy and methodology for predicting human PK evolving from a discovery to a First in Human setting.

Register to watch our webinar on-demand

You can ask your own questions of our experts.

Name(Required)

First Last

Company Name(Required)

Job Title(Required)

Country(Required)

State

Email(Required)

Thank you for registering to watch our on-demand webinar. By submitting this form, you consent to the collection and processing of your personal data by Pharmaron in accordance with our Privacy Policy. You may be contacted by email following your webinar viewing regarding any questions you may have, as well as relevant services and updates. You can unsubscribe or withdraw your consent at any time.

Agenda:

Intro to human extrapolation. Why? When? The Value.
- Different approaches to predictions, including PBPK’s role in discovery and in FiH predictions
- Model evolution: Discovery to clinic to filing
- Regulatory guidance awareness
Core data requirements for an extrapolation
- Physchem, ADME (Volume), and tissue composition
- Clearance
- Absorption (modelling)
- Fa, Fg, Fh
- Transporters
Case study
- Simple extrapolations
- PBPK model development and assumptions
- Utility of model (DDI predictions, concs drive PKPD model, and dose predictions)

Meet our Speakers

Moderated by:

Chris Bode, Ph.D. – VP Scientific and Corporate Communications at Absorption Systems, a Pharmaron company

Speakers:

Hannah Jones – Vice President, Head of PBPK Consulting Services at Certara UK Limited, Simcyp Division

Hannah Jones is the Vice President of PBPK Consulting within the Simcyp Division of Certara. In this role, Hannah leads a team of approximately 30 PBPK consultants who support discovery and development programs using the Simcyp Simulator. In particular, Hannah and her team use the Simcyp Simulator for human PK prediction, DDI prediction, special population prediction and biopharmaceutics modelling.

Hannah previously worked at Pfizer Inc, Cambridge, MA, US, Pfizer Ltd, Sandwich, UK and at F. Hoffmann La Roche, Basel, Switzerland. Her roles at Pfizer and Roche focused on modelling and simulation of human pharmacokinetics and pharmacodynamics for discovery and early development small and large molecule compounds. Hannah received a BSc (Hons) in Pharmacology and a PhD in Drug Metabolism from the School of Biological Sciences and the School of Pharmacy at the University of Manchester, UK, respectively. Hannah is particularly interested in the mechanistic modelling of pharmacokinetics and pharmacodynamics and has many research publications in this area.

Simon Taylor – Vice President, DMPK at Pharmaron

Simon Taylor is Vice President of DMPK and is based in Hoddesdon, UK. He is responsible for DMPK/ADME and PKPD strategy for Pharmaron’s integrated drug discovery projects from early discovery through to IND submission. Prior to Pharmaron, Simon worked at GSK for 20 years leading DMPK and Quantitative Pharmacology teams and projects from the Hit Identification stage through to Phase 2. He has worked across respiratory, inflammation, oncology and cardiovascular therapy areas with drugs of varying routes of administration. Simon is a committee member of the DMDG and has tutored on the DMDG ‘PK in discovery’ course since 2010.

Simon has a BSc in Pharmacology from the University of Leeds and an MSc in Model Based Drug Development from the University of Manchester. He has co-authored over 30 scientific publications in the literature.